Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Gilles Lemasson"'
Autor:
Gilles Lemasson, Adama Traoré, Ludovic Kam, Pascal Niamba, Nina Korsaga/Somé, Fousséni Dao, Myriam Sanwidi, Fatou Barro/Traoré
Publikováno v:
Nasza Dermatologia Online, Vol 4, Iss 3, Pp 361-368 (2013)
Résumé Introduction: L’histoplasmose à Histoplasma capsulatum var. duboisii est une affection rare en Afrique. Les lésions cutanées localisées sont les plus fréquentes. Nous rapportons une forme disséminée chez un enfant immunocompétent.
Externí odkaz:
https://doaj.org/article/dd7dcce1b6384b22b11343e6ce3b864f
Autor:
Olivier Pradier, Ulrike Schick, Virginie Conan-Charlet, François Lucia, Gilles Lemasson, Alice Delafoy, Arnaud Uguen
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 279:343-351
To evaluate the Programmed Cell Death Ligand (PD-L1) expression at diagnosis and relapse in patients with head and neck carcinoma (HNSCC) treated with radio(chemo)therapy. PD-L1 immunohistochemistry was performed in tumor cells (TC) and immune cells
Autor:
Maxime Battistella, Brigitte Balme, Marie-Laure Jullie, Ute Zimmermann, Agnès Carlotti, Marie Crinquette, Eric Frouin, Nicolas Macagno, Nicolas Ortonne, Laurence Lamant, Arnaud de la Fouchardiere, Marie-Hélène Aubriot-lorton, Luc Durand, Nicolas Josselin, Frédéric Franck, Denis Chatelain, Gilles Lemasson, Marie-Paule Algros, Anne Durlach, Marie-Christine Machet, Philippe Courville, Amélie Osio, Alice Seris, Laurent Mortier, Thomas Jouary, Bernard Cribier
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2022, 163, pp.211-221. ⟨10.1016/j.ejca.2021.11.027⟩
European Journal of Cancer, 2022, 163, pp.211-221. ⟨10.1016/j.ejca.2021.11.027⟩
To prospectively assess the impact of expert pathological review of skin adnexal carcinoma diagnosis in France.From 2014 to 2019, 2573 samples from patients with newly diagnosed or suspected skin adnexal carcinomas were reviewed prospectively by expe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aa91b9f51bca732cc2520de9bc11068
https://hal.univ-reims.fr/hal-03602584
https://hal.univ-reims.fr/hal-03602584
Autor:
Manon Briolais, Gilles Lemasson, Pascale Marcorelles, Briac Guibourg, Françoise Ledé, Jean-Luc Grippari, Glen Le Flahec, Arnaud Uguen
Publikováno v:
Journal of Clinical Pathology. 73:116-119
Beyond targeted therapy for patients with BRAF-mutated melanomas and immunotherapy in patients lacking BRAF mutations, anti-MEK therapy has been proposed in patients with advanced melanomas harbouring BRAF fusions. BRAF fusions diagnosis in patients
Publikováno v:
Pediatric Dermatology. 37:557-558
Autor:
Glen, Le Flahec, Manon, Briolais, Briac, Guibourg, Gilles, Lemasson, Jean-Luc, Grippari, Francoise, Ledé, Pascale, Marcorelles, Arnaud, Uguen
Publikováno v:
Journal of clinical pathology. 73(2)
Beyond targeted therapy for patients with
Autor:
Corinne Alleaume, F. Grude, Arnaud Uguen, Nacr Eddine Achour, Daniel Ten Martin, Gilles Lemasson, A. Volant, Joseph Politis, Olivier Capitain, Claire Stampfli, Laurent Miglianico, Jérome Chettrit, Jean-François Ramée, Philippe Deguiral, Véronique Verriele, Claire Magois, Norbert Padilla, Annie Wdowik, Sophie Michalak, Murielle Broyer-Petit, Erick Gamelin, Pierre-Luc Etienne, Pierre Marie Girardot, Jean-Philippe Metges, Jean-Jacques Auger, Christian Laboisse, Roger Faroux, Serge Eloit, V. Klein, Fanny Marhuenda, A. Gourlaouen, Marie-Aude Coulon, Delphine Deniel Lagadec, Isabelle Cumin, Louis-Rémi De Ybarlucea, Christian Riche, Bruno Turlin, Olivier Dupuis, Alain Bargain, Eric Lavoine, Ludovic Rosenfeld, Alain Penchet, Jean-Luc Raoul, Jean-Yves Douillard, Viorel Vasiliu, Nathalie Heresbach, Yann Touchefeu, Karine Bideau, Frédéric Staroz
Publikováno v:
Open Journal of Internal Medicine. :56-67
Purpose: Although controversial, assessment of epidermal growth factor receptor (EGFR) expression is required for the approved indications of Cetuximab in metastatic colorectal cancer (mCRC). With the objective of improving patient selection, “ERBI
Autor:
Arnaud Uguen, Stéphanie Bouvier, Sandrine Duigou, Françoise Ledé, Pascale Marcorelles, Gilles Lemasson, Cédric Le Maréchal, Bruno Sassolas, Claude Férec, Matthieu Talagas, Delphine Legoupil, Sebastian Costa, Marc De Braekeleer, Paul Gueguen
Publikováno v:
Human Pathology. 46:1582-1591
NRAS and BRAF mutational status has become mandatory to treat patients with metastatic melanomas. Mutation-specific immunohistochemistry (IHC) can help analyze challenging tumor samples. We report our experience integrating NRASQ61R (SP174) and BRAFV
Autor:
Somé, Adama Traoré, Fousséni Dao, Traoré, Ludovic Kam, Gilles Lemasson, Pascal Niamba, Nina Korsaga, Myriam Sanwidi, F. Barro
Publikováno v:
Nasza Dermatologia Online, Vol 4, Iss 3, Pp 361-368 (2013)
Résumé Introduction: L’histoplasmose à Histoplasma capsulatum var. duboisii est une affection rare en Afrique. Les lésions cutanées localisées sont les plus fréquentes. Nous rapportons une forme disséminée chez un enfant immunocompétent.
Publikováno v:
Pigment Cell & Melanoma Research. 26:275-277